Your browser doesn't support javascript.
loading
Apolipoprotein L1 is transcriptionally regulated by SP1, IRF1 and IRF2 in hepatoma cells.
Wang, De-Ping; Yu, Zhao-Xi; He, Zong-Cun; Liao, Jin-Fu; Shen, Xue-Bin; Zhu, Peng-Li; Chen, Wan-Nan; Lin, Xu; Xu, Shang-Hua.
Afiliação
  • Wang DP; Department of Medical Intensive Care Unit, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Yu ZX; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • He ZC; Department of Endocrinology and Metabolism, Hongqi Hospital of MuDanJiang Medical College, Mudanjiang, China.
  • Liao JF; Department of Medical Intensive Care Unit, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Shen XB; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Zhu PL; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Chen WN; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Lin X; Department of Cardiology, Affiliated Nanping First Hospital, Fujian Medical University, Nanping, China.
  • Xu SH; Department of Medical Intensive Care Unit, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, China.
FEBS Lett ; 594(19): 3108-3121, 2020 10.
Article em En | MEDLINE | ID: mdl-32671843
ABSTRACT
Apolipoprotein L1 (APOL1) participates in lipid metabolism. Here, we investigate the mechanisms regulating APOL1 gene expression in hepatoma cells. We demonstrate that the -80-nt to +31-nt region of the APOL1 promoter, which contains one SP transcription factor binding GT box and an interferon regulatory factor (IRF) binding ISRE element, maintains the maximum activity. Mutation of the GT box and ISRE element dramatically reduces APOL1 promoter activity. EMSA and chromatin immunoprecipitation assay reveal that the transcription factors Sp1, IRF1 and IRF2 could interact with their cognate binding sites on the APOL1 promoter. Overexpression of Sp1, IRF1 and IRF2 increases promoter activity, leading to increased APOL1 mRNA and protein levels, while knockdown of Sp1, IRF1 and IRF2 has the opposite effects. These results demonstrate that the APOL1 gene could be regulated by Sp1, IRF1 and IRF2 in hepatoma cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transcrição Gênica / Regulação Neoplásica da Expressão Gênica / Fator de Transcrição Sp1 / Carcinoma Hepatocelular / Fator Regulador 1 de Interferon / Fator Regulador 2 de Interferon / Apolipoproteína L1 / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transcrição Gênica / Regulação Neoplásica da Expressão Gênica / Fator de Transcrição Sp1 / Carcinoma Hepatocelular / Fator Regulador 1 de Interferon / Fator Regulador 2 de Interferon / Apolipoproteína L1 / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article